Friday, June 26, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 844 of 1,261

  1. US 8580748

    Peptides for the treatment of hearing

    Compass Therapeutics LLC · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted

  2. AU 2012249536

    Methods and compositions using PDE4 inhibitors for the treatment and management of autoimmune and inflammatory diseases

    CELGENE CORP [CH] · Granted Nov 7, 2013 · Expires Nov 2, 2033

    granted

  3. US 8575119

    2′-chloroacetylenyl substituted nucleoside derivatives

    Enanta Pharmaceuticals, Inc. · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  4. US 8574545

    Labeled iodinated tropane formulation

    Alseres Pharmaceuticals, Inc. · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  5. US 8575185

    Compositions, synthesis, and methods of utilizing quinazolinedione derivatives

    REVIVA PHARMACEUTICALS, INC. · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  6. US 8575192

    Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  7. US 8575123

    Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components

    Tekmira Pharmaceuticals Corporation · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  8. US 8575312

    Compositions and methods of use for MGD-CSF in disease treatment

    Five Prime Therapeutics, Inc. · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  9. US 8575208

    Inhibitors of serine proteases

    Vertex Pharmaceuticals Incorporated · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  10. US 8575209

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  11. US 8575196

    Oligomer-opioid agonist conjugates

    Nektar Therapeutics · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  12. US 8575170

    Flurbiprofen analogs and methods of use in treating cancer

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  13. US 8575167

    Spiro compounds having stearoyl-CoA desaturase action

    Takeda Pharmaceutical Company Limited · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  14. US 8575165

    Methods for treating inflammatory disorders using 2,4-pyrimidinediamine compounds

    Rigel Pharmaceuticals, Inc. · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  15. US 8575154

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  16. US 8575121

    Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  17. US 8574653

    Intermittent flow extrusion process and food product

    Del Monte Corporation · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  18. US 8574618

    Perforated bioabsorbable oil film and methods for making the same

    ATRIUM MEDICAL CORPORATION · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  19. US 8575102

    Conjugates having a releasable linkage

    Nektar Therapeutics · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  20. US 8574468

    Benzo-fused heterocyclic chromophores for nonlinear optical devices

    United States of America as represented by the Secretary of the Air Force · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  21. US 8574853

    Monoclonal antibodies that neutralize anthrax toxins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  22. US 8574467

    Benzo-fused heterocyclic chromophores for nonlinear optical devices

    United States of America as represented by the Secretary of the Air Force · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  23. US 8575319

    Cleavable vaccine compositions and uses thereof and methods of making and using the same

    The Regents of the University of California · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  24. US 8575359

    Acid-sensitive linkers for drug delivery

    The Regents of the University of California · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.